The DEXA-PSYCH Study—dexamethasone for moderate-to-severe depression: study protocol for a double-blind, randomized, parallel-group, placebo-controlled trial

EU Clinical Trials Number 2022-501428-45-00, Registered 25th of July 2022 in the EU Clinical Trials Information System ( https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501428-45-00 ). WHO Universal Trial Identifier U1111-1280-7614.

Authors

Michael E. Benros (ORCID: https://orcid.org/0000-0003-4939-9465)
Philip Hansen (ORCID: https://orcid.org/0000-0002-6972-7852)
Troels Boldt Rømer (ORCID: https://orcid.org/0000-0002-0832-2667)
C. G. Frederiksen (ORCID: https://orcid.org/0000-0002-4475-7617)
Rune Haubo Bojesen Christensen

Institutions

University of Copenhagen (DK)
Copenhagen University Hospital (DK)

Publication Details

Journal: Trials
Published: 2025-08-25
DOI: https://doi.org/10.1186/s13063-025-08989-2
Primary Topic: Tryptophan and brain disorders
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Københavns Universitet
Novo Nordisk Fonden

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The DEXA-PSYCH Study—dexamethasone for moderate-to-severe depression: study protocol for a double-blind, randomized, parallel-group, placebo-controlled trial

Michael E. Benros, Philip Hansen, Troels Boldt Rømer, C. G. Frederiksen et al.

Aug 25, 2025

1 links

Trials

Tryptophan and brain disorders

article

The DEXA-PSYCH Study—dexamethasone for moderate-to-severe depression: study protocol for a double-blind, randomized, parallel-group, placebo-controlled trial

Michael E. Benros, Philip Hansen, Troels Boldt Rømer, C. G. Frederiksen, Rune Haubo Bojesen Christensen

August 25, 2025article en

Abstract

EU Clinical Trials Number 2022-501428-45-00, Registered 25th of July 2022 in the EU Clinical Trials Information System ( https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-501428-45-00 ). WHO Universal Trial Identifier U1111-1280-7614.

TrialsVol. 26(1)

University of Copenhagen (DK), Copenhagen University Hospital (DK)

Københavns Universitet, Novo Nordisk Fonden

Good health and well-being

Openalex Percentile: Top 79%

Tryptophan and brain disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The DEXA-PSYCH Study—dexamethasone for moderate-to-severe depression: study protocol for a double-blind, randomized, parallel-group, placebo-controlled trial — Michael E. Benros, Philip Hansen, et al. · Trials (2025) | TGRS Research Map | TGRS